Local Institution - 142 — Concord, California

Local Institution - 142 is a clinical research site located in Concord, California, United States 94520.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 142 has participated in 1 clinical trials.

Therapeutic areas: Lymphoma, Non-Hodgkin.

Sponsors: Celgene.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Concord

Browse all research sites in California · View every site in Concord

• John Muir Health Hospital, Concord Medical Center
• Mount Diablo Medical Center
• Novo Nordisk Investigational Site
• John Muir Medical Center-Concord Campus
• John Muir Medical Center-Concord
• John Muir Physician Network Clinical Research Center
• Research Site
• Bay Area Cancer Research Group
• Cancer Care Center at John Muir Health - Concord Campus
• John Muir Health
• GSK Investigational Site
• John Muir Physicians Network

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 142?

Local Institution - 142 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 142 conducted?

Local Institution - 142 has 1 clinical trials on record. Their work covers Lymphoma, Non-Hodgkin.

Is Local Institution - 142 accredited by Crixeo Clinical Trials?

Local Institution - 142 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 142?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.